Literature DB >> 32082942

Placental Barrier and Autism Spectrum Disorders: The Roles of Prolactin and Dopamine in the Developing Fetal Brain-Part II.

Atmaram Yarlagadda1,2,3,4,5, Ganesh Acharya1,2,3,4,5, Jayaprada Kasaraneni1,2,3,4,5, Christiane S Hampe1,2,3,4,5, Anita H Clayton1,2,3,4,5.   

Abstract

The inverse relationship between prolactin and dopamine is important in the context of treatment with antipsychotic medications in men and nonpregnant women with thought disorders. Likewise, increased levels of prolactin as confirmation of recent seizure and the reciprocal levels of prolactin and dopamine in both eclampsia (seizures) and pre-eclampsia might have significant potential effects on a growing fetus. In this article, we attempt to outline the influence of these associations on autism spectrum disorders (ASDs) in children born to mothers with established diagnoses of eclampsia and/or pre-eclampsia. Our previously published paper, "Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain," summarized evidence for dysregulated dopamine and prolactin levels in the etiology of ASDs and suggested a possible method for assessing whether such aberrations increase the risk of ASDs. The present paper as Part 2 expands on the published data that support this theory and proposes a study design to corroborate this hypothesis.
Copyright © 2019. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  autism; dopamine; placenta; prolactin

Year:  2019        PMID: 32082942      PMCID: PMC7006862     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  53 in total

Review 1.  Drugs, biogenic amine targets and the developing brain.

Authors:  Aliya L Frederick; Gregg D Stanwood
Journal:  Dev Neurosci       Date:  2009-04-17       Impact factor: 2.984

2.  Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation.

Authors:  E H Chartoff; B T Marck; A M Matsumoto; D M Dorsa; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

3.  Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders.

Authors:  P D Robinson; C K Schutz; F Macciardi; B N White; J J Holden
Journal:  Am J Med Genet       Date:  2001-04-15

4.  Hyperactivity and alteration of the midbrain dopaminergic system in maternally stressed male mice offspring.

Authors:  Gi Hoon Son; Sooyoung Chung; Dongho Geum; Sang Soo Kang; Wan Sung Choi; Kyungjin Kim; Sukwoo Choi
Journal:  Biochem Biophys Res Commun       Date:  2006-11-27       Impact factor: 3.575

5.  Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.

Authors:  Russell C Dale; Vera Merheb; Sekhar Pillai; Dongwei Wang; Laurence Cantrill; Tanya K Murphy; Hilla Ben-Pazi; Sophia Varadkar; Tim D Aumann; Malcolm K Horne; Andrew J Church; Thomas Fath; Fabienne Brilot
Journal:  Brain       Date:  2012-10-11       Impact factor: 13.501

6.  Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study.

Authors:  Lisa A Croen; Daniel Braunschweig; Lori Haapanen; Cathleen K Yoshida; Bruce Fireman; Judith K Grether; Martin Kharrazi; Robin L Hansen; Paul Ashwood; Judy Van de Water
Journal:  Biol Psychiatry       Date:  2008-06-20       Impact factor: 13.382

7.  Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.

Authors:  G W Lambert; G Eisenhofer; H S Cox; M Horne; V Kalff; M Kelly; G L Jennings; M D Esler
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

Review 8.  Mechanisms involved in the neurotoxic effects of environmental toxicants such as polychlorinated biphenyls and brominated flame retardants.

Authors:  Frode Fonnum; Espen Mariussen
Journal:  J Neurochem       Date:  2009-10-10       Impact factor: 5.372

Review 9.  Model of autism: increased ratio of excitation/inhibition in key neural systems.

Authors:  J L R Rubenstein; M M Merzenich
Journal:  Genes Brain Behav       Date:  2003-10       Impact factor: 3.449

10.  Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model.

Authors:  Harvey S Singer; Christina Morris; Colin Gause; Matthew Pollard; Andrew W Zimmerman; Mikhail Pletnikov
Journal:  J Neuroimmunol       Date:  2009-04-10       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.